These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8463899)

  • 1. Relationship of genotype to early pulmonary function in infants with cystic fibrosis identified through neonatal screening.
    Mohon RT; Wagener JS; Abman SH; Seltzer WK; Accurso FJ
    J Pediatr; 1993 Apr; 122(4):550-5. PubMed ID: 8463899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
    Ranieri E; Lewis BD; Gerace RL; Ryall RG; Morris CP; Nelson PV; Carey WF; Robertson EF
    BMJ; 1994 Jun; 308(6942):1469-72. PubMed ID: 8019280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural history.
    Green MR; Weaver LT; Heeley AF; Nicholson K; Kuzemko JA; Barton DE; McMahon R; Payne SJ; Austin S; Yates JR
    Arch Dis Child; 1993 Apr; 68(4):464-7. PubMed ID: 8503667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
    Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
    N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.
    Britton LJ; Oates GR; Oster RA; Self ST; Troxler RB; Hoover WC; Gutierrez HH; Harris WT
    Pediatr Pulmonol; 2016 Nov; 51(11):1168-1176. PubMed ID: 27556254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal energy expenditure in the infant with presymptomatic cystic fibrosis.
    Bronstein MN; Davies PS; Hambidge KM; Accurso FJ
    J Pediatr; 1995 Jan; 126(1):28-33. PubMed ID: 7815219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    Hammond KB; Abman SH; Sokol RJ; Accurso FJ
    N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased energy expenditure in cystic fibrosis is associated with specific mutations.
    O'Rawe A; McIntosh I; Dodge JA; Brock DJ; Redmond AO; Ward R; Macpherson AJ
    Clin Sci (Lond); 1992 Jan; 82(1):71-6. PubMed ID: 1310920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
    Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
    BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
    Klaassen T; Teder M; Viikmaa M; Metspalu A
    J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis.
    Thomson MA; Wilmott RW; Wainwright C; Masters B; Francis PJ; Shepherd RW
    J Pediatr; 1996 Sep; 129(3):367-73. PubMed ID: 8804325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study.
    Borgo G; Gasparini P; Bonizzato A; Cabrini G; Mastella G; Pignatti PF
    Eur J Pediatr; 1993 Dec; 152(12):1006-11. PubMed ID: 8131801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results].
    Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J
    Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
    Kerem E; Corey M; Kerem BS; Rommens J; Markiewicz D; Levison H; Tsui LC; Durie P
    N Engl J Med; 1990 Nov; 323(22):1517-22. PubMed ID: 2233932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.